CIDEL ASSET MANAGEMENT INC

Position in ABBV — AbbVie Inc.

CIK 1621915 TORONTO, A6

Position in ABBV

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$2,329,934

+$388,184 QoQ

Shares Held

9,259

+3.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#1,851

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CIDEL ASSET MANAGEMENT INC holds $84,525,882 across 11 Drug Manufacturers - General names. ABBV ranks #6 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	234,663	$44,496,798
2	LLY	ELI LILLY & Co	19,854	$23,813,485
3	JNJ	Johnson & Johnson	16,136	$4,098,059
4	MRK	Merck & Co., Inc.	18,925	$2,431,862
5	PFE	Pfizer Inc	97,941	$2,358,419
6	ABBV	AbbVie Inc. This page	9,259	$2,329,934
7	BMY	Bristol Myers Squibb Co	33,042	$1,903,880
8	AMGN	Amgen Inc	3,794	$1,373,883

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,329,934	9,259	+3.7%	Shares	Sole	2026-07-17
2026-03-31	$1,941,750	8,928	+19.3%	Shares	Sole	2026-04-17
2025-12-31	$1,709,790	7,483	-2.5%	Shares	Sole	2026-01-21
2025-09-30	$1,777,532	7,677	+3.3%	Shares	Sole	2025-11-07
2025-06-30	$1,379,156	7,430	+1.8%	Shares	Sole	2025-07-29
2025-03-31	$1,529,286	7,299	+1.5%	Shares	Sole	2025-04-28
2024-12-31	$1,278,373	7,194	+3.1%	Shares	Sole	2025-01-28
2024-09-30	$1,378,607	6,981	0.0%	Shares	Sole	2024-11-04
2024-06-30	$1,197,381	6,981	+5.6%	Shares	Sole	2024-07-22
2024-03-31	$1,204,045	6,612	+1.8%	Shares	Sole	2024-05-08
2023-12-31	$1,006,840	6,497	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.